EMBRACing a new PARP inhibitor?

被引：0
|
作者：
Diana Romero
机构：
[1] Nature Reviews Clinical Oncology,
来源：
Nature Reviews Clinical Oncology | 2018年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：655 / 655
相关论文
共 50 条
  • [21] PARP inhibitor has antitumor activity
    Mandy Aujla
    [J]. Nature Reviews Clinical Oncology, 2009, 6 (9) : 496 - 496
  • [22] PARP inhibitor response in prostate cancer
    Louise Stone
    [J]. Nature Reviews Urology, 2023, 20 : 130 - 130
  • [23] The Principles and Practice of PARP Inhibitor Therapy
    Yap, Timothy A.
    Coleman, Robert L.
    [J]. CANCER JOURNAL, 2021, 27 (06): : 430 - 431
  • [24] PARP inhibitor approved, despite vote
    不详
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (02) : 116 - 116
  • [25] Discovery and development of PARP inhibitor senaparib
    Cai, Sui Xiong
    Ma, Ning
    Wang, Xiaozhu
    Jiang, Yangzhen
    Guo, Mingchuan
    Hsieh, Chih-Yi
    Tian, Ye Edward
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [26] Mechanisms of PARP inhibitor sensitivity and resistance
    D'Andrea, Alan D.
    [J]. DNA REPAIR, 2018, 71 : 172 - 176
  • [27] PARP inhibitor combinations in prostate cancer
    Pezaro, Carmel
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [28] In vivo visualization of PARP inhibitor pharmacodynamics
    McDonald, Elizabeth S.
    Pantel, Austin R.
    Shah, Payal D.
    Farwell, Michael D.
    Clark, Amy S.
    Doot, Robert K.
    Pryma, Daniel A.
    Carlin, Sean D.
    [J]. JCI INSIGHT, 2021, 6 (08)
  • [29] Predicting PARP inhibitor sensitivity and resistance
    Bebb, D. Gwyn
    Lees-Miller, Susan P.
    [J]. CELL CYCLE, 2012, 11 (22) : 4110 - 4110
  • [30] PARP inhibitor approved, despite vote
    [J]. Nature Biotechnology, 2015, 33 : 116 - 116
12345